source
- FDA rejects ivonescimab for lung cancer; J&J to acquire Ollin Biosciences for up to $3.3B, Senate votes on FDA commissionerThe FDA has denied the application for ivonescimab as a treatment for lung cancer, halting its development for that indication. Johnson & Johnson announced a deal to purchase Ollin Biosciences, a…
- Study finds plastic particles in brains of dementia patients, prompting re-evaluation of disease theoriesResearchers at the University of New Mexico reported the presence of microscopic plastic deposits surrounding blood vessels in the brains of individuals who died from dementia. The findings were pr…